Novolin Ge 30/70 70 Unit

NOVOLIN GE 30/70 70 Unit is a human biosynthetic insulin suspension used for managing blood sugar levels. This subcutaneous injection is designed for diabetes care, offering a balanced mix of rapid and intermediate-acting insulin.

NOVOLIN GE 30/70 70 Unit is primarily used for controlling high blood sugar in individuals with diabetes. This insulin suspension combines rapid-acting and intermediate-acting insulin to provide both immediate and prolonged glucose control. It is often prescribed for those requiring consistent blood sugar management throughout the day and night.

Common effects of NOVOLIN GE 30/70 70 Unit may include localized reactions at the injection site, such as redness or itching. Some users might experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. These effects vary among individuals and typically subside as the body adjusts to the medication.

NOVOLIN GE 30/70 70 Unit should be stored properly to maintain its efficacy. It is essential to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Regular monitoring of blood sugar levels is recommended to ensure optimal management of diabetes.

NOVOLIN GE 30/70 70 Unit may interact with other medications, including oral hypoglycemic agents, beta-blockers, and certain antibiotics. Alcohol consumption can also affect blood sugar levels and should be monitored closely. Always consult a healthcare provider before starting or stopping any medication while using this insulin suspension.